Thrombocytopenia
Showing 1 - 25 of 7,346
Outcome of Thrombocytopenia in ICU Patients
Not yet recruiting
- Thrombocytopenia
- (no location specified)
Jul 15, 2023
Acute Ischemic Stroke, Thrombocytopenia Trial (aspirin, clopidogrel, cilostazol, and dipyridamole)
Not yet recruiting
- Acute Ischemic Stroke
- Thrombocytopenia
- aspirin, clopidogrel, cilostazol, and dipyridamole
- (no location specified)
Sep 21, 2023
Acute Suspected Heparin-induced Thrombocytopenia.
Not yet recruiting
- Heparin-induced Thrombocytopenia
-
Paris, FranceHopital Bichat-Claude Bernard
Sep 28, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)
Not yet recruiting
- Myelofibrosis
- Moderate Thrombocytopenia
- (no location specified)
Jul 31, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Ketogenic Diet Trial (Strict ketogenic diet group, Cyclic ketogenic diet group, Autonomous ketogenesis group)
Not yet recruiting
- Ketogenic Diet
- Strict ketogenic diet group
- +2 more
- (no location specified)
Oct 26, 2023
Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)
Not yet recruiting
- Thrombocytopenia
- Hepatocellular Carcinoma
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023
Chemo-induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-induced Thrombocytopenia
- (no location specified)
Oct 20, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag
- +2 more
- (no location specified)
May 17, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)
Recruiting
- Immune Thrombocytopenia Purpura
- Dexamethasone
- +4 more
-
Cairo, EgyptEL-Kasr elineiy
May 6, 2023
Antiphospholipid Syndrome, Thrombocytopenia Trial in Tianjin (Anti-CD38 antibody Injection)
Recruiting
- Antiphospholipid Syndrome
- Thrombocytopenia
- Anti-CD38 antibody Injection
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Heparin-induced Thrombocytopenia, HIT, Platelet Activation Trial in Amiens (blood sample)
Recruiting
- Heparin-induced Thrombocytopenia
- +7 more
- blood sample
-
Amiens, FranceCHU Amiens
Sep 12, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Linezolid Induced Thrombocytopenia Trial in Cairo (N acetyl cysteine)
Not yet recruiting
- Linezolid Induced Thrombocytopenia
- N acetyl cysteine
-
Cairo, Egypt15 May hospital
Jul 6, 2023
Linezolid-induced Thrombocytopenia in Critically Ill Patients,
Recruiting
- Thrombocytopenia; Drugs
- Linezolid 600 mg
-
Cairo, Egypt15 May hospital
Jul 13, 2023
Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +2 more
- (no location specified)
Jun 26, 2023
Pediatric Primary Immune Thrombocytopenia (ITP)
Recruiting
- Primary Immune Thrombocytopenia
- data collection
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023
Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)
Not yet recruiting
- Thrombocytopenia, Immune
- Heparin Induced Thrombocytopenia
- VLX-1005
- Placebo
- (no location specified)
Mar 24, 2023
Study of Severe Fever With Thrombocytopenia Syndrome
Recruiting
- Severe Fever With Thrombocytopenia Syndrome
-
Guangshui, Hubei, China
- +7 more
Aug 21, 2023
Sjogren Syndrome With Other Organ Involvement Trial (Hydroxychloroquine, Tacrolimus)
Not yet recruiting
- Sjogren Syndrome With Other Organ Involvement
- (no location specified)
Dec 28, 2022